Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history now shows a new site revision (v3.4.2) replacing v3.4.1; there are no substantive updates to study records or page content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry (v3.4.1) was added and the previous revision (v3.4.0) removed. This is a minor metadata update to the page history with no impact on study content or data.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page adds a Show glossary option and color-coded indicators for changes (green for additions, red for deletions). The revision label was updated to v3.4.0, replacing the previous v3.3.4.SummaryDifference0.9%

- Check42 days agoChange DetectedA new revision (v3.3.4) was added to the study record history, and the previous revision (v3.3.3) was removed, indicating a bookkeeping update to the page.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Revision: v3.3.3 was added to the study record history, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed from the page.SummaryDifference0.2%

- Check85 days agoChange DetectedThe revision history shows a minor update with an addition of Revision: v3.3.2 and deletion of Revision: v3.3.1. These changes are system maintenance details and do not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.